World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
46
Citations
7064
World Ranking
6747
National Ranking
2922

Overview

Gerard B. Fox is affiliated with Georgetown University Medical Center in the United States. Their research spans several fields within medicine, with a notable focus on oncology, neurology, radiology, nuclear medicine, imaging, epidemiology, and economics and econometrics.

Their work covers a range of key topics, including:

  • HER2/EGFR in Cancer Research
  • Colorectal Cancer Treatments and Studies
  • Radiopharmaceutical Chemistry and Applications
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Acute Ischemic Stroke Management
  • Cinema and Media Studies

Recent publications by Gerard B. Fox highlight an interdisciplinary approach, reflected in work published between 2021 and 2024. These include:

  • "A Phase 1 and Biodistribution Study of ABT-806i, an 111In-Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806" (2021, Journal of Nuclear Medicine)
  • "Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery Occlusion" (2023, Translational Stroke Research)
  • "Stim Cinema" (2024, Moving Image Review & Art Journal (MIRAJ))

The scientist has collaborated with several frequent co-authors, including Hui Gan, Matthew Burge, Benjamin Solomon, Sze Ting Lee, and Kyle D. Holen. This collaboration network spans the domains of medicine and media studies, complementing the diversity of research topics covered.

Gerard B. Fox's publications appear in journals that reflect a varied but focused academic interest, such as:

  • Journal of Nuclear Medicine
  • Translational Stroke Research
  • Moving Image Review & Art Journal (MIRAJ)

The combination of subfields and topics reveals a scientist engaged in both clinical and experimental research, particularly in areas related to cancer biology, neurological disorders including stroke and traumatic brain injury, and emerging intersections with media studies.

Best Publications

  • Activation of CPP32-Like Caspases Contributes to Neuronal Apoptosis and Neurological Dysfunction after Traumatic Brain Injury

    Alexander G. Yakovlev;Susan M. Knoblach;Lei Fan;Gerard B. Fox

  • Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist

    Gerard B. Fox;Timothy A. Esbenshade;Jia Bao Pan;Richard J. Radek

  • Sustained Sensory/Motor and Cognitive Deficits With Neuronal Apoptosis Following Controlled Cortical Impact Brain Injury in the Mouse

    Gerard B. Fox;Lei Fan;Ryan A. Levasseur;Alan I. Faden

  • Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders.

    Timothy A Esbenshade;Gerard B Fox;Marlon D Cowart

  • Effects of histamine H3 receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup

    Gerard B Fox;Jia Bao Pan;Timothy A Esbenshade;Youssef L Bennani

  • Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and Selective Histamine H3 Receptor Antagonist with Drug-Like Properties

    Timothy A. Esbenshade;Gerard B. Fox;Kathleen M. Krueger;Thomas R. Miller

  • 4-(2-[2-(2(R)-Methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and Related 2-Aminoethylbenzofuran H3 Receptor Antagonists Potently Enhance Cognition and Attention

    Marlon Cowart;Ramin Faghih;Michael P. Curtis;Gregory A. Gfesser

  • Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization.

    Gerard B. Fox;Jia Bao Pan;Richard J. Radek;Angela M. Lewis

  • Effect of traumatic brain injury on mouse spatial and nonspatial learning in the Barnes circular maze.

    Gerard B. Fox;Lei Fan;Ryan A. LeVASSEUR;Alan I. Faden

  • Memory consolidation induces a transient and time-dependent increase in the frequency of neural cell adhesion molecule polysialylated cells in the adult rat hippocampus.

    Gerard B. Fox;Alan W. O'Connell;Keith J. Murphy;Ciaran M. Regan

  • Two Novel and Selective Nonimidazole Histamine H3 Receptor Antagonists A-304121 and A-317920: I. In Vitro Pharmacological Effects

    Timothy A. Esbenshade;Kathleen M. Krueger;Thomas R. Miller;Chae Hee Kang

  • Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.

    Timothy A Esbenshade;Gerard B Fox;Kathleen M Krueger;John L Baranowski

  • Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist.

    Arthur A. Hancock;Youssef L. Bennani;Eugene N. Bush;Timothy A. Esbenshade

  • Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging

    Betty B. Yao;Gin Hsieh;Anthony V. Daza;Yihong Fan

  • Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan.

    Kaitlin E Browman;Victoria A Komater;Peter Curzon;Lynne E Rueter

  • The Behavioral Assessment of Sensorimotor Processes in the Mouse: Acoustic Startle, Sensory Gating, Locomotor Activity, Rotarod, and Beam Walking

    Peter Curzon;Min Zhang;Richard J. Radek;Gerard B. Fox

  • Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test.

    Ana M Basso;Kelly B Gallagher;Natalie A Bratcher;Jorge D Brioni

  • Default-mode-like network activation in awake rodents.

    Jaymin Upadhyay;Scott J. Baker;Prasant Chandran;Loan Miller

  • Awake rat pharmacological magnetic resonance imaging as a translational pharmacodynamic biomarker: metabotropic glutamate 2/3 agonist modulation of ketamine-induced blood oxygenation level dependence signals.

    Chih-Liang Chin;Jaymin Upadhyay;Gerard J Marek;Scott J Baker

  • H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization

    Victoria A. Komater;Kaitlin E. Browman;Peter Curzon;Arthur A. Hancock

  • Preclinical Characterization of A‐582941: A Novel α7 Neuronal Nicotinic Receptor Agonist with Broad Spectrum Cognition‐Enhancing Properties

    Karin R. Tietje;David J. Anderson;R. Scott Bitner;Eric A. Blomme

  • Perspectives on cognitive domains, H3 receptor ligands and neurological disease

    Arthur A Hancock;Gerard B Fox

Frequent Co-Authors

Prisca Honore
Prisca Honore University of Minnesota
Steve McGaraughty
Steve McGaraughty AbbVie (United States)
Randall J. Bateman
Randall J. Bateman Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Gerard B. Fox

Trending Scientists